| MolName | 3-[(5Z)-5-[[2-(2-morpholin-4-yl-2-oxoethoxy)phenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]propanoic acid |
| MolecularFormula | C19H20N2O6S2 |
| Smiles | OC(CCN(C(/C(/S1)=C/c(cccc2)c2OCC(N2CCOCC2)=O)=O)C1=S)=O |
| InChI | InChI=1S/C19H20N2O6S2/c22-16(20-7-9-26-10-8-20)12-27-14-4-2-1-3-13(14)11-15-18(25)21(19(28)29-15)6-5-17(23)24/h1-4,11H,5-10,12H2,(H,23,24) |
| InChIK | SOPOVZVSMBHHOH-UHFFFAOYSA-N |
| TotalMolweight | 436.508 |
| Molweight | 436.508 |
| MonoisotopicMass | 436.076278 |
| CLogP | 0.2307 |
| CLogS | -2.673 |
| H Acceptors | 8 |
| H Donors | 1 |
| TotalSurfaceArea | 317.69 |
| Relative PSA | 0.39287 |
| PolarSurfaceArea | 153.77 |
| Druglikeness | 4.1873 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | |
| Shape Index | 0.58621 |
| Fragments | 1 |
| Non HAtoms | 29 |
| NonCHAtoms | 10 |
| Electronegative Atoms | 10 |
| Rotatable Bond | 7 |
| Rings Closures | 3 |
| Small Rings | 3 |
| Aromatic Rings | 1 |
| Aromatic Atoms | 6 |
| Sp3Atoms | 12 |
| Symmetricatoms | 2 |
| Amides | 2 |
| AcidicOxygens | 1 |
| StereoCon |
Click to Load Molecule:
1 - 3-[(5Z)-5-[[2-(2-morpholin-4-yl-2-oxoethoxy)phenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]propanoic acid | 2 - 3-[(5Z)-5-[[2-(2-morpholin-4-yl-2-oxoethoxy)phenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]propanoic acid